Skip to main content
Erschienen in: Annals of Hematology 11/2011

01.11.2011 | Review Article

Postpartum anemia I: definition, prevalence, causes, and consequences

verfasst von: Nils Milman

Erschienen in: Annals of Hematology | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

This review provides a status on the definition, prevalence, causes, and consequences of anemia in women who have given childbirth, i.e., postpartum anemia. The diagnosis of iron deficiency anemia relies on a full blood count including hemoglobin, serum ferritin, and serum soluble transferrin receptor, which appear to be reliable indicators of anemia and iron status 1 week postpartum while serum transferrin saturation is an unreliable indicator several weeks after delivery. It is recommended that postpartum anemia should be defined by hemoglobin <110 g/L at 1 week postpartum and <120 g/L at 8 weeks postpartum. The major causes of postpartum anemia are prepartum anemia combined with acute bleeding anemia due blood losses at delivery. Normal peripartum blood losses are approximately 300 ml, but hemorrhage >500 ml occur in 5–6% of the women. In healthy women after normal delivery, the prevalence of anemia (hemoglobin <110 g/L) 1 week postpartum is 14% in iron-supplemented women and 24% in non-supplemented women. In consecutive series of European women, the prevalence of anemia 48 h after delivery is approximately 50%. In developing countries, the prevalence of postpartum anemia is in the range of 50–80%. Postpartum anemia is associated with an impaired quality of life, reduced cognitive abilities, emotional instability, and depression and constitutes a significant health problem in women of reproductive age.
Literatur
1.
2.
Zurück zum Zitat Protonotariou E, Chrelias C, Kassanos D, Kapsambeli H, Trakakis E, Sarandakou A (2010) Immune response parameters during labor and early neonatal life. In Vivo 24:117–123PubMed Protonotariou E, Chrelias C, Kassanos D, Kapsambeli H, Trakakis E, Sarandakou A (2010) Immune response parameters during labor and early neonatal life. In Vivo 24:117–123PubMed
3.
Zurück zum Zitat Bodnar LM, Siega-Riz AM, Miller WC, Cogswell ME, McDonald T (2002) Who should be screened for postpartum anemia? An evaluation of current recommendations. Am J Epidemiol 156:903–912PubMedCrossRef Bodnar LM, Siega-Riz AM, Miller WC, Cogswell ME, McDonald T (2002) Who should be screened for postpartum anemia? An evaluation of current recommendations. Am J Epidemiol 156:903–912PubMedCrossRef
4.
Zurück zum Zitat Bergmann RL, Richter R, Bergmann KE, Dudenhausen JW (2010) Prevalence and risk factors for early postpartum anemia. Eur J Obstet Gynecol Reprod Biol 150:126–131PubMedCrossRef Bergmann RL, Richter R, Bergmann KE, Dudenhausen JW (2010) Prevalence and risk factors for early postpartum anemia. Eur J Obstet Gynecol Reprod Biol 150:126–131PubMedCrossRef
5.
Zurück zum Zitat Åkesson A, Bjellerup P, Berglund M, Bremme K, Vahter M (1998) Serum transferrin receptor: a specific marker of iron deficiency in pregnancy. Am J Clin Nutr 68:1241–1246PubMed Åkesson A, Bjellerup P, Berglund M, Bremme K, Vahter M (1998) Serum transferrin receptor: a specific marker of iron deficiency in pregnancy. Am J Clin Nutr 68:1241–1246PubMed
6.
Zurück zum Zitat Åkesson A, Bjellerup P, Berglund M, Bremme K, Vahter M (2002) Soluble transferrin receptor: longitudinal assessment from pregnancy to postlactation. Obstet Gynecol 99:260–266PubMedCrossRef Åkesson A, Bjellerup P, Berglund M, Bremme K, Vahter M (2002) Soluble transferrin receptor: longitudinal assessment from pregnancy to postlactation. Obstet Gynecol 99:260–266PubMedCrossRef
7.
Zurück zum Zitat Milman N, Byg K-E, Bergholt T, Eriksen L, Hvas A-M (2006) Body iron and individual iron prophylaxis in pregnancy—should the iron dose be adjusted according to serum ferritin? Ann Hematol 85:567–573PubMedCrossRef Milman N, Byg K-E, Bergholt T, Eriksen L, Hvas A-M (2006) Body iron and individual iron prophylaxis in pregnancy—should the iron dose be adjusted according to serum ferritin? Ann Hematol 85:567–573PubMedCrossRef
8.
Zurück zum Zitat Goetzl L, Manevich Y, Roedner C, Praktish A, Hebbar L, Townsend DM (2010) Maternal and fetal oxidative stress and intrapartum term fever. Am J Obstet Gynecol 202(363):e1–e5PubMed Goetzl L, Manevich Y, Roedner C, Praktish A, Hebbar L, Townsend DM (2010) Maternal and fetal oxidative stress and intrapartum term fever. Am J Obstet Gynecol 202(363):e1–e5PubMed
9.
Zurück zum Zitat Larsson A, Palm M, Hansson L-O, Basu S, Axelsson O (2008) Reference values for α1-acid glycoprotein, α1-antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and IgM during pregnancy. Acta Obstet Gynecol Scand 87:1084–1088PubMedCrossRef Larsson A, Palm M, Hansson L-O, Basu S, Axelsson O (2008) Reference values for α1-acid glycoprotein, α1-antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and IgM during pregnancy. Acta Obstet Gynecol Scand 87:1084–1088PubMedCrossRef
10.
Zurück zum Zitat Breymann C, Richter C, Hüttner C, Huch R, Huch A (2000) Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anemia and blunted erythropoiesis. Eur J Clin Invest 30:154–161PubMedCrossRef Breymann C, Richter C, Hüttner C, Huch R, Huch A (2000) Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anemia and blunted erythropoiesis. Eur J Clin Invest 30:154–161PubMedCrossRef
11.
Zurück zum Zitat Wågström E, Åkesson A, Van Rooijen M, Larson B, Bremme K (2007) Erythropietin and intravenous iron therapy in postpartum anemia. Acta Obstet Gynecol Scand 86:957–962PubMedCrossRef Wågström E, Åkesson A, Van Rooijen M, Larson B, Bremme K (2007) Erythropietin and intravenous iron therapy in postpartum anemia. Acta Obstet Gynecol Scand 86:957–962PubMedCrossRef
12.
Zurück zum Zitat Hendrick V, Altshuler LL, Suri R (1998) Hormonal changes in the postpartum and implications for postpartum depression. Psychosomatics 39:93–101PubMed Hendrick V, Altshuler LL, Suri R (1998) Hormonal changes in the postpartum and implications for postpartum depression. Psychosomatics 39:93–101PubMed
13.
Zurück zum Zitat Lee W, Pivarnik J (1992) Hemodynamic studies during pregnancy. J Matern Fetal Med 1:75–77CrossRef Lee W, Pivarnik J (1992) Hemodynamic studies during pregnancy. J Matern Fetal Med 1:75–77CrossRef
14.
Zurück zum Zitat Varga I, Rigó J Jr, Somos P, Joó JG, Nagy B (2000) Analysis of maternal circulation and renal function in physiologic pregnancies; parallel examinations of the changes in the cardiac output and the glomerular filtration rate. J Matern Fetal Med 9:97–104PubMedCrossRef Varga I, Rigó J Jr, Somos P, Joó JG, Nagy B (2000) Analysis of maternal circulation and renal function in physiologic pregnancies; parallel examinations of the changes in the cardiac output and the glomerular filtration rate. J Matern Fetal Med 9:97–104PubMedCrossRef
15.
Zurück zum Zitat Milman N, Agger OA, Nielsen OJ (1991) Iron supplementation during pregnancy. Effect on iron status markers, serum erythropoietin and human placental lactogen. A placebo controlled study in 207 Danish women. Dan Med Bull 38:471–476PubMed Milman N, Agger OA, Nielsen OJ (1991) Iron supplementation during pregnancy. Effect on iron status markers, serum erythropoietin and human placental lactogen. A placebo controlled study in 207 Danish women. Dan Med Bull 38:471–476PubMed
16.
Zurück zum Zitat Koller O (1982) The clinical significance of hemodilution during pregnancy. Obstet Gynecol Surv 37:649–652PubMedCrossRef Koller O (1982) The clinical significance of hemodilution during pregnancy. Obstet Gynecol Surv 37:649–652PubMedCrossRef
17.
Zurück zum Zitat World Health Organization (2001) Iron deficiency anemia. Assessment, prevention, and control. WHO/NHD/01.3 World Health Organization (2001) Iron deficiency anemia. Assessment, prevention, and control. WHO/NHD/01.3
18.
Zurück zum Zitat Bodnar LM, Cogswell ME, Scanlon KS (2002) Low income postpartum women are at risk of iron deficiency. J Nutr 132:2298–2302PubMed Bodnar LM, Cogswell ME, Scanlon KS (2002) Low income postpartum women are at risk of iron deficiency. J Nutr 132:2298–2302PubMed
19.
Zurück zum Zitat Milman N, Byg K-E, Graudal N, Agger AO (2000) Reference values for hemoglobin and erythrocyte indices during normal pregnancy in 206 women with and without iron supplementation. Acta Obstet Gynecol Scand 78:89–98CrossRef Milman N, Byg K-E, Graudal N, Agger AO (2000) Reference values for hemoglobin and erythrocyte indices during normal pregnancy in 206 women with and without iron supplementation. Acta Obstet Gynecol Scand 78:89–98CrossRef
20.
Zurück zum Zitat Milman N, Bergholdt T, Byg K-E, Eriksen L, Hvas A-M (2007) Reference intervals for haematological variables during normal pregnancy and postpartum in 433 healthy Danish women. Eur J Haematol 79:39–46PubMedCrossRef Milman N, Bergholdt T, Byg K-E, Eriksen L, Hvas A-M (2007) Reference intervals for haematological variables during normal pregnancy and postpartum in 433 healthy Danish women. Eur J Haematol 79:39–46PubMedCrossRef
21.
Zurück zum Zitat Milman N, Ibsen KK, Christensen JM (1987) Serum ferritin and iron status in mothers and newborn infants. Acta Obstet Gynecol Scand 66:205–211PubMedCrossRef Milman N, Ibsen KK, Christensen JM (1987) Serum ferritin and iron status in mothers and newborn infants. Acta Obstet Gynecol Scand 66:205–211PubMedCrossRef
22.
Zurück zum Zitat Somdatta P, Reddaiah VP, Singh B (2009) Prevalence of anemia in the postpartum period: a study of a North Indian village. Trop Doct 39:211–215PubMedCrossRef Somdatta P, Reddaiah VP, Singh B (2009) Prevalence of anemia in the postpartum period: a study of a North Indian village. Trop Doct 39:211–215PubMedCrossRef
23.
Zurück zum Zitat Richter C, Huch A, Huch R (1995) Erythropoiesis in the postpartum period. J Perinat Med 23:51–59PubMedCrossRef Richter C, Huch A, Huch R (1995) Erythropoiesis in the postpartum period. J Perinat Med 23:51–59PubMedCrossRef
24.
Zurück zum Zitat Milman N, Bergholt T, Eriksen L, Byg K-E, Graudal N, Pedersen P, Hertz J (2005) Iron prophylaxis during pregnancy—how much iron is needed? A randomised, controlled study of 20 to 80 mg ferrous iron daily to pregnant women. Acta Obstet Gynecol Scand 84:238–247PubMed Milman N, Bergholt T, Eriksen L, Byg K-E, Graudal N, Pedersen P, Hertz J (2005) Iron prophylaxis during pregnancy—how much iron is needed? A randomised, controlled study of 20 to 80 mg ferrous iron daily to pregnant women. Acta Obstet Gynecol Scand 84:238–247PubMed
25.
Zurück zum Zitat Milman N (2011) Anemia—still a major health problem in many parts of the world! Ann Hematol 90:369–377PubMedCrossRef Milman N (2011) Anemia—still a major health problem in many parts of the world! Ann Hematol 90:369–377PubMedCrossRef
26.
Zurück zum Zitat Milman N, Byg K-E, Hvas A-M, Bergholt T, Eriksen L (2006) Erythrocyte folate, plasma folate and plasma homocysteine during normal pregnancy and postpartum: a longitudinal study comprising 404 Danish women. Eur J Haematol 76:200–205PubMedCrossRef Milman N, Byg K-E, Hvas A-M, Bergholt T, Eriksen L (2006) Erythrocyte folate, plasma folate and plasma homocysteine during normal pregnancy and postpartum: a longitudinal study comprising 404 Danish women. Eur J Haematol 76:200–205PubMedCrossRef
27.
Zurück zum Zitat Milman N, Byg K-E, Bergholt T, Eriksen L, Hvas A-M (2006) Cobalamin status during normal pregnancy and postpartum. A longitudinal study comprising 406 Danish women. Eur J Haematol 76:521–525PubMedCrossRef Milman N, Byg K-E, Bergholt T, Eriksen L, Hvas A-M (2006) Cobalamin status during normal pregnancy and postpartum. A longitudinal study comprising 406 Danish women. Eur J Haematol 76:521–525PubMedCrossRef
28.
Zurück zum Zitat Mørkbak AL, Hvas A-M, Milman N, Nexø E (2007) Holotranscobalamin remains unchanged during pregnancy. Longitudinal changes of cobalamins and their binding proteins during pregnancy and postpartum. Haematologica 92:1711–1712PubMedCrossRef Mørkbak AL, Hvas A-M, Milman N, Nexø E (2007) Holotranscobalamin remains unchanged during pregnancy. Longitudinal changes of cobalamins and their binding proteins during pregnancy and postpartum. Haematologica 92:1711–1712PubMedCrossRef
29.
Zurück zum Zitat Milman N, Byg K-E, Ovesen L (2000) Iron status in Danes updated 1994. II. Prevalence of iron deficiency and iron overload on 1319 women aged 40–70 years. Influence of blood donation, alcohol intake, and iron supplementation. Ann Hematol 79:612–621PubMedCrossRef Milman N, Byg K-E, Ovesen L (2000) Iron status in Danes updated 1994. II. Prevalence of iron deficiency and iron overload on 1319 women aged 40–70 years. Influence of blood donation, alcohol intake, and iron supplementation. Ann Hematol 79:612–621PubMedCrossRef
30.
Zurück zum Zitat Milman N, Clausen J, Byg K-E (1998) Iron status in 268 Danish women aged 18–30 years. Influence of menstruation, method of contraception, and iron supplementation. Ann Hematol 76:13–19CrossRef Milman N, Clausen J, Byg K-E (1998) Iron status in 268 Danish women aged 18–30 years. Influence of menstruation, method of contraception, and iron supplementation. Ann Hematol 76:13–19CrossRef
31.
Zurück zum Zitat Nybo M, Friis-Hansen L, Felding P, Milman N (2007) Higher prevalence of anemia among pregnant immigrant women compared to pregnant ethnic Danish women. Ann Hematol 86:647–651PubMedCrossRef Nybo M, Friis-Hansen L, Felding P, Milman N (2007) Higher prevalence of anemia among pregnant immigrant women compared to pregnant ethnic Danish women. Ann Hematol 86:647–651PubMedCrossRef
32.
Zurück zum Zitat Waldmann A, Koschizke JW, Leitzmann C, Hahn A (2004) Dietary iron intake and iron status of German female vegans: results of the German vegan study. Ann Nutr Metab 48:103–108PubMedCrossRef Waldmann A, Koschizke JW, Leitzmann C, Hahn A (2004) Dietary iron intake and iron status of German female vegans: results of the German vegan study. Ann Nutr Metab 48:103–108PubMedCrossRef
33.
Zurück zum Zitat Harvey LJ, Armah CN, Dainty JR, Foxall RJ, John Lewis D, Fairweather-Tait SJ (2005) Impact of menstrual blood loss and diet iron on iron deficiency among women in the UK. Br J Nutr 94:557–564PubMedCrossRef Harvey LJ, Armah CN, Dainty JR, Foxall RJ, John Lewis D, Fairweather-Tait SJ (2005) Impact of menstrual blood loss and diet iron on iron deficiency among women in the UK. Br J Nutr 94:557–564PubMedCrossRef
34.
Zurück zum Zitat Milman N, Søndergaard M, Sørensen CM (1985) Iron stores in female blood donors evaluated by serum ferritin. Blut 51:337–345PubMedCrossRef Milman N, Søndergaard M, Sørensen CM (1985) Iron stores in female blood donors evaluated by serum ferritin. Blut 51:337–345PubMedCrossRef
35.
Zurück zum Zitat Milman N, Kirchhoff M (1991) Influence of blood donation on iron stores assessed by serum ferritin and haemoglobin in a population survey of 1359 Danish women. Ann Hematol 62:27–32CrossRef Milman N, Kirchhoff M (1991) Influence of blood donation on iron stores assessed by serum ferritin and haemoglobin in a population survey of 1359 Danish women. Ann Hematol 62:27–32CrossRef
36.
Zurück zum Zitat Milman N, Kirchhoff M, Jørgensen T (1992) Iron status markers, ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity and postmenopausal hormone treatment. Ann Hematol 65:96–102PubMedCrossRef Milman N, Kirchhoff M, Jørgensen T (1992) Iron status markers, ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity and postmenopausal hormone treatment. Ann Hematol 65:96–102PubMedCrossRef
37.
Zurück zum Zitat Milman N (2006) Iron prophylaxis in pregnancy—general or individual and in which dose? Ann Hematol 85:821–828PubMedCrossRef Milman N (2006) Iron prophylaxis in pregnancy—general or individual and in which dose? Ann Hematol 85:821–828PubMedCrossRef
38.
Zurück zum Zitat Makrides M, Crowther CA, Gibson RA, Gibson RS, Skeaff CM (2003) Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomised controlled trial. Am J Clin Nutr 78:145–153PubMed Makrides M, Crowther CA, Gibson RA, Gibson RS, Skeaff CM (2003) Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomised controlled trial. Am J Clin Nutr 78:145–153PubMed
40.
Zurück zum Zitat Rajan PV, Wing DA (2010) Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment. Clin Obstet Gynecol 53:165–181PubMedCrossRef Rajan PV, Wing DA (2010) Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment. Clin Obstet Gynecol 53:165–181PubMedCrossRef
41.
Zurück zum Zitat Groot AN, van Roosmalen J, van Dongen PW, Borm GF (1996) A placebo-controlled trial of oral ergometrine to reduce postpartum hemorrhage. Acta Obstet Gynecol Scand 75:464–468PubMedCrossRef Groot AN, van Roosmalen J, van Dongen PW, Borm GF (1996) A placebo-controlled trial of oral ergometrine to reduce postpartum hemorrhage. Acta Obstet Gynecol Scand 75:464–468PubMedCrossRef
42.
Zurück zum Zitat Gilbert L, Porter W, Brown VA (1987) Postpartum haemorrhage—a continuing problem. British Journal of Obstetrics and Gynaecology 94:67–671PubMedCrossRef Gilbert L, Porter W, Brown VA (1987) Postpartum haemorrhage—a continuing problem. British Journal of Obstetrics and Gynaecology 94:67–671PubMedCrossRef
43.
Zurück zum Zitat Kavle JA, Khalfan SS, Stoltzfus RJ, Witter F, Tielsch JM, Caulfield LE (2006) Measurement of blood loss at childbirth and postpartum. Int J Gynecol Obstet 95:24–28CrossRef Kavle JA, Khalfan SS, Stoltzfus RJ, Witter F, Tielsch JM, Caulfield LE (2006) Measurement of blood loss at childbirth and postpartum. Int J Gynecol Obstet 95:24–28CrossRef
44.
Zurück zum Zitat Roberts CL, Ford JB, Thomson JF, Morris JM (2008) Population rates of hemorrhage and transfusions among obstetric patients in NSW: a short communication. Aust N Z J Obstet Gynaecol 48:481–484PubMedCrossRef Roberts CL, Ford JB, Thomson JF, Morris JM (2008) Population rates of hemorrhage and transfusions among obstetric patients in NSW: a short communication. Aust N Z J Obstet Gynaecol 48:481–484PubMedCrossRef
45.
Zurück zum Zitat Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B (2008) Prevalence and risk factors of severe obstetric hemorrhage. BJOG 115:1265–1272PubMedCrossRef Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B (2008) Prevalence and risk factors of severe obstetric hemorrhage. BJOG 115:1265–1272PubMedCrossRef
46.
Zurück zum Zitat Oyelese Y, Ananth CV (2010) Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol 53:147–156PubMedCrossRef Oyelese Y, Ananth CV (2010) Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol 53:147–156PubMedCrossRef
47.
Zurück zum Zitat Newton M (1966) Postpartum hemorrhage. Am J Obstet Gynecol 94:711–717PubMed Newton M (1966) Postpartum hemorrhage. Am J Obstet Gynecol 94:711–717PubMed
49.
Zurück zum Zitat Rouse DJ, MacPherson C, Landon M, Varner MW, Leveno KJ, Moawad AH et al (2006) Blood transfusion and cesarean delivery. Obstet Gynecol 108:891–897PubMedCrossRef Rouse DJ, MacPherson C, Landon M, Varner MW, Leveno KJ, Moawad AH et al (2006) Blood transfusion and cesarean delivery. Obstet Gynecol 108:891–897PubMedCrossRef
50.
Zurück zum Zitat Bruner A, Joffe A, Duggan AK, Casella JF, Brandt J (1996) Randomised study of cognitive effects of iron supplementation in non-anemic iron-deficient adolescent girls. Lancet 348:992–996PubMedCrossRef Bruner A, Joffe A, Duggan AK, Casella JF, Brandt J (1996) Randomised study of cognitive effects of iron supplementation in non-anemic iron-deficient adolescent girls. Lancet 348:992–996PubMedCrossRef
51.
Zurück zum Zitat Rowland TW, Deisroth MB, Green GM, Kelleher JF (1988) The effect of iron therapy on the exercise capacity of non-anemic iron-deficient adolescent runners. Am J Dis Childhood 142:165–169 Rowland TW, Deisroth MB, Green GM, Kelleher JF (1988) The effect of iron therapy on the exercise capacity of non-anemic iron-deficient adolescent runners. Am J Dis Childhood 142:165–169
52.
Zurück zum Zitat Gibbs R (1980) Clinical risk factors for puerperal infection. Obstet Gynecol 55(Suppl 5):178S–184SPubMed Gibbs R (1980) Clinical risk factors for puerperal infection. Obstet Gynecol 55(Suppl 5):178S–184SPubMed
53.
Zurück zum Zitat Vora M, Gruslin A (1998) Erythropoietin in obstetrics. Obstetrical and Gynecological Survey 53:500–508PubMedCrossRef Vora M, Gruslin A (1998) Erythropoietin in obstetrics. Obstetrical and Gynecological Survey 53:500–508PubMedCrossRef
54.
Zurück zum Zitat Beard JL, Hendricks MK, Perez EM et al (2005) Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr 135:267–272PubMed Beard JL, Hendricks MK, Perez EM et al (2005) Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr 135:267–272PubMed
55.
Zurück zum Zitat Corwin EJ, Murray-Kolb LE, Beard JL (2003) Low hemoglobin level is a risk factor for postpartum depression. J Nutr 133:4139–4142PubMed Corwin EJ, Murray-Kolb LE, Beard JL (2003) Low hemoglobin level is a risk factor for postpartum depression. J Nutr 133:4139–4142PubMed
56.
Zurück zum Zitat Beard JL, Hendricks MK, Perez EM, Murray-Kolb LE, Berg A, Vernon-Feagans L, Irlam J, Isaacs W, Sive A, Tomlinson M (2005) Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr 135:267–272PubMed Beard JL, Hendricks MK, Perez EM, Murray-Kolb LE, Berg A, Vernon-Feagans L, Irlam J, Isaacs W, Sive A, Tomlinson M (2005) Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr 135:267–272PubMed
57.
Zurück zum Zitat Meyer JW, Eichhorn KH, Vetter K, Christen S, Schleusner E, Klos A, Huch A, Huch R (1995) Does recombinant human erythropoietin not only treat anemia but reduce postpartum (emotional) distress as well? J Perinat Med 23:99–109PubMedCrossRef Meyer JW, Eichhorn KH, Vetter K, Christen S, Schleusner E, Klos A, Huch A, Huch R (1995) Does recombinant human erythropoietin not only treat anemia but reduce postpartum (emotional) distress as well? J Perinat Med 23:99–109PubMedCrossRef
58.
Zurück zum Zitat Murray-Kolb LE, Beard JL (2009) Iron deficiency and child and maternal health. Am J Clin Nutr 89:946S–950SPubMedCrossRef Murray-Kolb LE, Beard JL (2009) Iron deficiency and child and maternal health. Am J Clin Nutr 89:946S–950SPubMedCrossRef
59.
Zurück zum Zitat World Health Organization. Reduction of maternal mortality. A joint WHO/UNFPA/UNICEF/World Bank statement. Geneva: World Health Organization, 1999 World Health Organization. Reduction of maternal mortality. A joint WHO/UNFPA/UNICEF/World Bank statement. Geneva: World Health Organization, 1999
60.
Zurück zum Zitat Potts M, Campbell M (2004) Three meetings and fewer funerals: misoprostol in postpartum hemorrhage. Lancet 364:1110–1111PubMedCrossRef Potts M, Campbell M (2004) Three meetings and fewer funerals: misoprostol in postpartum hemorrhage. Lancet 364:1110–1111PubMedCrossRef
61.
Zurück zum Zitat Tsu VD, Shane B (2004) New and underutilized technologies to reduce maternal mortality: call to action from a Bellagio workshop. Int J Gynecol Obstet 85(Suppl 1):S83–S93CrossRef Tsu VD, Shane B (2004) New and underutilized technologies to reduce maternal mortality: call to action from a Bellagio workshop. Int J Gynecol Obstet 85(Suppl 1):S83–S93CrossRef
62.
Zurück zum Zitat Recommendation to prevent and control iron deficiency in the United States. MMWR Morb Mortal Wkly Rep 1998; 47(RR-3):13–25 Recommendation to prevent and control iron deficiency in the United States. MMWR Morb Mortal Wkly Rep 1998; 47(RR-3):13–25
Metadaten
Titel
Postpartum anemia I: definition, prevalence, causes, and consequences
verfasst von
Nils Milman
Publikationsdatum
01.11.2011
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 11/2011
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-011-1279-z

Weitere Artikel der Ausgabe 11/2011

Annals of Hematology 11/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.